Dr. Michal Bar-Natan, MD
Claim this profileIcahn School of Medicine at Mount Sinai
Area of expertise
Burkitt's Leukemia
Michal Bar-Natan, MD has run 3 trials for Burkitt's Leukemia. Some of their research focus areas include:
Leukemia
Michal Bar-Natan, MD has run 3 trials for Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Mount Sinai Hospital
Icahn School Of Medicine At Mount Sinai
Clinical Trials Michal Bar-Natan, MD is currently running
ABL001 Combo Therapy
for Leukemia
This research study is evaluating a drug called ABL001 taken in combination with dasatinib (Sprycel®) and prednisone (a steroid) as a possible treatment for B-cell Acute Lymphoblastic Leukemia that is BCR-ABL positive (BCR-ABL+ B-ALL) or Chronic Myeloid Leukemia (CML) in lymphoid blast crisis. BCR-ABL+ B-ALL is also called Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL). It is expected that 40-65 people will take part in this research study. * ABL001 * Dasatinib (Sprycel®) * Prednisone * Blinatumomab
Recruiting
1 award
Phase 1
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia
This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy drug called ozogamicin. Inotuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD22 receptors, and delivers ozogamicin to kill them. Chemotherapy drugs, such as \[intervention\], work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.
Recruiting
2 awards
Phase 3
3 criteria
More about Michal Bar-Natan, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Michal Bar-Natan, MD has experience with
- Cytarabine
- ABL001
- Dasatinib
- Prednisone
- Mutant CALR-peptide Based Vaccine
- Allopurinol
Breakdown of trials Michal Bar-Natan, MD has run
Burkitt's Leukemia
Leukemia
Chronic Myeloid Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michal Bar-Natan, MD specialize in?
Michal Bar-Natan, MD focuses on Burkitt's Leukemia and Leukemia. In particular, much of their work with Burkitt's Leukemia has involved BCR-ABL1 positive patients, or patients who are CD19 positive.
Is Michal Bar-Natan, MD currently recruiting for clinical trials?
Yes, Michal Bar-Natan, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michal Bar-Natan, MD has studied deeply?
Yes, Michal Bar-Natan, MD has studied treatments such as Cytarabine, ABL001, Dasatinib.
What is the best way to schedule an appointment with Michal Bar-Natan, MD?
Apply for one of the trials that Michal Bar-Natan, MD is conducting.
What is the office address of Michal Bar-Natan, MD?
The office of Michal Bar-Natan, MD is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.